Current stock page

Stock Analysis

Humana Inc. (HUM) Stock Analysis

Humana Inc. (HUM) stock analysis covering valuation, fundamentals, technical indicators, risk, AIQ Momentum, analyst catalysts, dividends, and the current AIQ Score.

HUM Stock Analysis Summary

Humana Inc. (HUM) currently has an AIQ Score of 71/100, indicating a bullish setup. Momentum is the strongest factor at 89/100. Quality is the weakest current factor at 50/100. Technical, fundamental, catalyst, dividend, and risk evidence should be read together at the latest market-close snapshot.

Updated Nov 13, 2026 · Market-close data

HUM at a Glance

Crawlable current metrics from the latest market-close stock snapshot.

MetricCurrent
Price$450.00
AIQ Score71/100
Overall ViewBullish
Technical Analysis ConsensusStrong Buy
Market Cap$54.04B
P/E Ratio (TTM)43.35
Forward P/E—
EPS (Q3 FY2026)$1.35
Revenue (Q3 FY2026)$41.16B
Dividend Yield (TTM)0.79%
Beta0.54
Volume1.5M
52-week range$163.11-$456.50
RSI 1464.5
50-Day SMA$408.68
200-Day SMA$317.35
Analyst Price Target$508.40
Next EarningsFeb 10, 2027
As of Nov 13, 2026 · Market close

HUMHumana Inc.

Healthcare / Medical - Healthcare Plans

Leader

Strong Relative Position

BullishEdge 9/10
$450.00+$6.32 (+1.42%)

Latest quote

  • Momentum
    89
  • Value
    76
  • Quality
    50
  • Risk resilience
    67
  • Sentiment
    —
algovestiq.comScore data as of Nov 13, 2026

HUM Stock Analysis Summary

Humana Inc. (HUM) currently has an AIQ Score of 71/100, indicating a bullish setup. Momentum is the strongest factor at 89/100. Quality is the weakest current factor at 50/100. Technical, fundamental, catalyst, dividend, and risk evidence should be read together at the latest market-close snapshot.

Updated Nov 13, 2026 · Market-close data
AIQ Composite Posture: Bullish

In a bullish regime, HUM has AIQ Score of 71/100 with Momentum base of 89/100 and fading Quality at 50/100. Wait for component alignment before adding exposure.

Signal Conflict Detected

Momentum (89/100) leads while Quality (50/100) lags. This cross-factor spread creates entry timing uncertainty.

Healthcare · 1.42% stock move · HUM classified in Medical - Healthcare Plans.

Current Evidence

BullishHUM is in a bullish AIQ regime; Momentum is the strongest visible factor at 89/100.
Core coverage reflects visible evidence only

AlgovestIQ Evidence Summary

Current consensus, supporting evidence, recent changes, and what would strengthen or weaken the view.

Is HUM Bullish or Bearish Right Now?

HUM currently has a bullish overall setup. Momentum is the strongest factor at 89/100, while Quality is weakest at 50/100. The current evidence suggests a constructive setup.

Bull Case
  • - Momentum is constructive at 89/100.
  • - Risk Resilience is supportive at 67/100.
  • - Price is +10.11% above its 50-day SMA.
  • - Analyst target implies +12.98% upside from the latest quote.
  • - Technical consensus has more buy votes than sell votes (35 vs 8).
Bear Case
  • - No strong bearish evidence is available in the current snapshot.

Current Consensus

HUM's Technical Analysis Consensus is currently Strong Buy, with 35 buy, 3 neutral, and 8 sell votes. HUM's 14-day RSI is 64.5, which places the stock in a constructive momentum range. HUM's beta is 0.54, indicating lower market sensitivity than the broad market.

Signal Confidence
High agreement

What Changed in HUM?

The largest recent change in HUM is Quality moving up by 3.0 points over the available 7-day comparison window. Momentum remains the strongest visible factor.

AIQ Score
+2.0
Momentum
+1.0
Quality
+3.0
Risk
+1.0

What Would Change the HUM Outlook?

The current bullish outlook could improve if AIQ reaches 65 (Bullish), momentum recovers, earnings revisions strengthen, and price confirms a stronger trend above the 50-day and 200-day moving averages. It would weaken if AIQ falls below 50 (Bearish), price loses long-term moving-average support, analyst expectations deteriorate, or risk evidence worsens.

Bullish confirmation

AIQ 65+ (Bullish), RSI above 55, price above SMA-50/SMA-200, and positive catalyst or estimate-revision evidence.

Bearish deterioration

AIQ below 50 (Bearish), RSI below 45, loss of SMA-200, negative revisions, or rising volatility and drawdown risk.

HUM Decision Framework

Public evidence layers, setup checks, and risk context for Humana Inc..

Humana Inc. (HUM) Stock Analysis

Humana Inc. has an AIQ Score of 71/100 in a Bullish regime. Momentum is strongest at 89/100. Beta is 0.54, below market sensitivity. Review the supporting stock factors together before drawing a conclusion from any single score.

Evidence LayerPublic Evidence
Regime ContextHUM is in a Bullish AIQ regime with score 71/100.
Signal ConflictThe primary conflict is that momentum leads at 89/100 while quality lags at 50/100.
Factor EvidenceMomentum 89/100 · Value 76/100 · Quality 50/100 · Risk 67/100
PersistenceCurrent snapshot evidence is shown; historical persistence remains in AIQ Pro.

Current Setup Checklist

Factor strengthPass

Momentum is the strongest factor at 89/100.

TimingPass

Momentum is 89/100 and RSI (14) is 64.5.

Regime fitPass

HUM is in a Bullish regime at 71/100.

Risk controlPass

Risk factor is 67/100 with beta 0.54 and annual volatility 46.03%.

ConflictWait

Current conflict: momentum leads at 89/100 while quality lags at 50/100.

AIQ Score
71/100
Price
$450.00
Beta
0.54
RSI (14)
64.5

HUM Research Cluster

Ticker-specific paths for valuation, technical analysis, catalysts, dividends, financials, risk, and news.

HUM Fundamentals

HUM valuation, profitability, growth, margins, balance-sheet strength, and free cash flow.

Revenue
$41.16B
Net income
$162M
Free cash flow
$2.03B
View full HUM fundamental analysis

HUM Technical Analysis

HUM technical setup based on RSI, MACD, moving averages, AIQ Momentum, volume, trend, volatility, and pivots.

Technical Analysis Consensus
Strong Buy
RSI 14
64.5
Price vs SMA-50
+10.11%
View full HUM technical analysis

HUM Stock Catalysts

Track HUM earnings, analyst ratings, price targets, estimate revisions, stock news, and upcoming events.

Next earnings
Feb 10, 2027
Analyst target
$508.40
News items
5
View HUM earnings and stock catalysts

HUM Dividend Analysis

HUM dividend yield, annual dividend, payout ratio, payment history, and income reliability context.

Dividend yield
0.79%
Annual dividend
$3.54
Payout ratio
34.46%
View HUM dividend history and analysis

HUM Financial Data

HUM revenue, earnings, income statement, balance sheet, cash flow, valuation ratios, and stock metrics.

Quarter revenue
$41.16B
EPS
$1.35
Periods
8
View HUM financials

HUM Risk Analysis

HUM volatility, beta, drawdown, Sharpe ratio, VaR, and downside resilience.

Beta
0.54
Risk score
67/100
1Y volatility
46.03%
View HUM risk analysis

HUM Stock News

HUM stock news, market tone, recent headlines, and catalyst context.

News items
5
Updated
Nov 15, 2026
Sentiment
—
Read HUM stock news

HUM vs Healthcare Services / Managed Care Peers

Current peer cohort: HUM · IQV · LFST · LH · MCK. Compare AIQ, factor scores, Sharpe ratio and 1-year volatility in one indexable view.

PeerAIQValueMomentumRiskSharpe1Y VolatilityCompare
HUM
Current stock
71/10076/10089/10067/1001.5546.03%Current
IQV
IQVIA Holdings
70/10079/10081/10066/1000.5340.72%HUM vs IQV
LFST
LifeStance Health
67/10029/10089/10071/1001.9444.50%HUM vs LFST
LH
Labcorp
73/10081/10079/10083/1001.324.18%HUM vs LH
MCK
McKesson
76/10077/10091/10082/1000.8731.74%HUM vs MCK
Pairwise Compare links: IQV · LFST · LH · MCKHUM vs IQVHUM vs LFSTHUM vs LHHUM vs MCKCompare cohort

Peer cohort is resolved dynamically from the AlgovestIQ universe taxonomy and Compare relationship graph. Data as of Nov 13, 2026.

About the AIQ Score

Methodology for the current stock evidence.

As of Nov 13, 2026 · Market close

The AlgovestIQ AIQ Score combines multiple dimensions of stock evidence, including momentum, valuation exposure, quality, risk resilience, sentiment context, and timing signals. It is a descriptive research score, not a guarantee of future performance or a personalized recommendation.

View AIQ methodology

Factor Diagnostics

A compact bridge from the AIQ score to the evidence tabs.

Calculator
Calculate a HUM stock return scenario

Open the return calculator with stock context while purchase price, shares, dates and fees remain user inputs.

Calculate stock return

Also for HUM: historical return with reinvested dividends and stock average calculator for several buys.

AIQ Component Profile

Compare the five component scores on one consistent 0–100 scale.

Catalyst preview

Review earnings timing, revisions, news pressure, and prior event reactions in one place.

Open catalysts
Quarterly evidence

8 recent quarterly periods are available for review.

Checked Nov 16, 2026

AIQ Pro

Explore factor drivers, conflicts, persistence, and scenario sensitivity in the advanced workspace.

Fundamentals Verdict

Current snapshot fields are separate from reported-quarter statement tables.

Current TTM P/E
43.35
As of Nov 13, 2026
Revenue growth
26.05%
Gross margin
13.01%
Current debt / equity
0.66
Latest quarterly evidence

Latest period Sep 30, 2026.

Review fundamentals
Quarter revenue
$41.16B
Quarter net income
$162M
Quarter free cash flow
$2.03B

Market Confirmation

Technicals are summarized first, with the indicator library behind it.

Trend
Bullish
Momentum
Bullish
RSI 14
64.5
MACD
9.34

Risk Alignment

Higher resilience is stronger; exposure metrics stay separate.

Resilience
67/100
Beta
0.54
Annual volatility
46.03%
Max drawdown
-42.36%

HUM Stock FAQ

What is HUM stock price today?

Humana Inc.'s current stock price is $450.00. Use the live quote with AIQ Score, news, and risk context rather than treating price alone as a decision signal.

Is HUM bullish or bearish right now?

HUM's bullish or bearish read depends on the current AIQ Score, factor alignment, technical analysis consensus, valuation, risk, and catalyst evidence. A mixed setup should be treated differently from a broad confirmation across those signals.

What is HUM's market cap?

HUM's market cap is $54.04B based on the latest completed market-close snapshot from Nov 13, 2026. Use it with P/E ratio, revenue, and growth metrics to frame company size, valuation, and peer comparisons.

What is HUM's current P/E ratio?

HUM's current P/E ratio is 43.35 based on the latest completed market-close snapshot from Nov 13, 2026. Read it with revenue growth, margins, EPS, cash flow, and peer valuation rather than using P/E alone.

What is HUM's RSI?

HUM's 14-day RSI is 64.5 based on the latest completed market-close snapshot from Nov 13, 2026. RSI should be interpreted with MACD, moving averages, volume, volatility, and price trend.

Is HUM above its 50-day and 200-day moving averages?

HUM is 10.11% from its 50-day SMA and 41.80% from its 200-day SMA based on the latest completed market-close snapshot from Nov 13, 2026. Moving-average position should be read with momentum and broader AIQ evidence.

When is HUM's next earnings date?

HUM's next earnings date is currently listed as Feb 10, 2027. Earnings can reset revenue, EPS, price target, analyst rating, and catalyst expectations.

Does HUM pay a dividend?

HUM's dividend yield is 0.79% based on the latest completed market-close snapshot from Nov 13, 2026. Dividend yield should be read with payout ratio, free cash flow, growth, and balance-sheet strength.